The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakano, A.
Right arrow Articles by Kido, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakano, A.
Right arrow Articles by Kido, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH

The Journal of Immunology, Vol 159, Issue 4 1987-1992, Copyright © 1997 by American Association of Immunologists

ARTICLES

Selective conversion of big endothelins to tracheal smooth muscle- constricting 31-amino acid-length endothelins by chymase from human mast cells

A Nakano, F Kishi, K Minami, H Wakabayashi, Y Nakaya and H Kido
Division of Enzyme Chemistry, Institute for Enzyme Research, The University of Tokushima, Japan.

Chymase from human mast cells selectively cleaved big endothelins (ETs) at the Tyr31-Gly32 bond and produced novel trachea-constricting 31- amino acid-length endothelins, ETs(1-31), without any further degradation products. Chymases from other species, such as the enzymes from rat connective tissue and mucosal mast cells, and the other chymotrypsin-like proteases examined degraded big ETs. ETs(1-31) exhibited various contractile potencies as to the rat trachea in comparison with 21-amino acid-length endothelins, ETs(1-21), and big ETs: ET-1(1-21) > ET-1(1-31) > big ET-1; ET-2(1-31) > ET-2(1-21) > or = big ET-2; ET-3(1-21) > or = ET-3(1-31) > or = big ET-3. Among the ETs(1- 31), ET-2(1-31) was the most potent constrictor, its potency being similar to that of ET-1(1-21) and stronger than that of ET-2(1-21). The contractile activity of ETs(1-31) may not be the consequence of conversion to the corresponding ETs(1-21) by phosphoramidon-sensitive ET-converting enzymes or other chymotrypsin-type proteases and metalloendopeptidases, because the contractile activity was not inhibited significantly on treatment with inhibitors of these proteases before the addition of ET-1(1-31). Inhibitors of chymotrypsin-type serine proteases, on the contrary, significantly enhanced the contractile activity exhibited by ET-1(1-31) and big ET-1, but not that by ET-1(1-21). These results suggest that protease(s) on the surface of the rat trachea tends to degrade ETs(1-31) and big ETs, and thereby reduces their contractile activity. Taken together, the results suggest that trachea-constricting ETs(1-31) generated by human chymase may play a role in the hyper-responsive airway in allergic inflammation.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
E. Simard, D. Jin, S. Takai, M. Miyazaki, I. Brochu, and P. D'Orleans-Juste
Chymase-Dependent Conversion of Big Endothelin-1 in the Mouse in Vivo
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 540 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. K. Andersson, M. Enoksson, M. Gallwitz, and L. Hellman
The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile
Int. Immunol., January 1, 2009; 21(1): 95 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
Y. Wang, Y. Gu, and D. F. Lewis
Endothelial Angiotensin II Generation Induced by Placenta-derived Factors From Preeclampsia
Reproductive Sciences, November 1, 2008; 15(9): 932 - 938.
[Abstract] [PDF]

Home page
 IOVSHome page
S. Ghavami, M. Hashemi, F. J. de Serres, S. N. Bajestani, H. Mehrabifar, and A. Leonardi
Trypsin Inhibitory Capacity in Vernal Keratoconjunctivitis
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 264 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
A.-J. Ren, X. Yuan, L. Lin, J. Xu, T. Chen, W.-Z. Wang, X.-H. Yan, Y.-W. Qing, C.-S. Tang, and W.-J. Yuan
Arrhythmogenic action of endothelin-11-31 through conversion to endothelin-11-21.
Experimental Biology and Medicine, June 1, 2006; 231(6): 937 - 941.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
P. G. Trentin, M. B. Fernandes, P. D'Orleans-Juste, and G. A. Rae
Endothelin-1 causes pruritus in mice.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1146 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Papassotiriou, N. G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann
Immunoluminometric Assay for Measurement of the C-Terminal Endothelin-1 Precursor Fragment in Human Plasma
Clin. Chem., June 1, 2006; 52(6): 1144 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Kinoshita, M. Okada, M. Hara, Y. Furukawa, and A. Matsumori
Mast Cell Tryptase in Mast Cell Granules Enhances MCP-1 and Interleukin-8 Production in Human Endothelial Cells
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1858 - 1863.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M.-H. Fecteau, J.-C. Honore, M. Plante, J. Labonte, G. A. Rae, and P. D'Orleans-Juste
Endothelin-1 (1-31) Is an Intermediate in the Production of Endothelin-1 After Big Endothelin-1 Administration In Vivo
Hypertension, July 1, 2005; 46(1): 87 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero
Role of Endothelin in the Pathogenesis of Hypertension
Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
W. W. Raymond, S. W. Ruggles, C. S. Craik, and G. H. Caughey
Albumin Is a Substrate of Human Chymase: PREDICTION BY COMBINATORIAL PEPTIDE SCREENING AND DEVELOPMENT OF A SELECTIVE INHIBITOR BASED ON THE ALBUMIN CLEAVAGE SITE
J. Biol. Chem., September 5, 2003; 278(36): 34517 - 34524.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. L. Lazaar, M. I. Plotnick, U. Kucich, I. Crichton, S. Lotfi, S. K. P. Das, S. Kane, J. Rosenbloom, R. A. Panettieri Jr., N. M. Schechter, et al.
Mast Cell Chymase Modifies Cell-Matrix Interactions and Inhibits Mitogen-Induced Proliferation of Human Airway Smooth Muscle Cells
J. Immunol., July 15, 2002; 169(2): 1014 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. V Agapitov and W. G Haynes
Role of endothelin in cardiovascular disease
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 1 - 15.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. P. Metsarinne, P. Vehmaan-Kreula, P. T. Kovanen, O. Saijonmaa, M. Baumann, Y. Wang, T. Nyman, F. Y. Fyhrquist, and K. K. Eklund
Activated Mast Cells Increase the Level of Endothelin-1 mRNA in Cocultured Endothelial Cells and Degrade the Secreted Peptide
Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 268 - 273.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. P. Rossi, P. G. Andreis, S. Colonna, G. Albertin, F. Aragona, A. S. Belloni, and G. G. Nussdorfer
Endothelin-1[1-31]: A Novel Autocrine-Paracrine Regulator of Human Adrenal Cortex Secretion and Growth
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 322 - 328.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Levy, M. Gordin, R. Mamluk, M. Yanagisawa, M. F. Smith, J. H. Hampton, and R. Meidan
Distinct Cellular Localization and Regulation of Endothelin-1 and Endothelin-Converting Enzyme-1 Expression in the Bovine Corpus Luteum: Implications for Luteolysis
Endocrinology, December 1, 2001; 142(12): 5254 - 5260.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
C. FERNANDEZ-PATRON, C. ZOUKI, R. WHITTAL, J. S. D. CHAN, S. T. DAVIDGE, and J. G. FILEP
Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]
FASEB J, October 1, 2001; 15(12): 2230 - 2240.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
P. Cui, K. Tani, H. Kitamura, Y. Okumura, M. Yano, D. Inui, T. Tamaki, S. Sone, and H. Kido
A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes
J. Leukoc. Biol., August 1, 2001; 70(2): 306 - 312.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. F. Luscher and M. Barton
Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs
Circulation, November 7, 2000; 102(19): 2434 - 2440.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. Arakawa and H. Urata
Hypothesis Regarding the Pathophysiological Role of Alternative Pathways of Angiotensin II Formation in Atherosclerosis
Hypertension, October 1, 2000; 36(4): 638 - 641.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Hara, A. Matsumori, K. Ono, H. Kido, M.-W. Hwang, T. Miyamoto, A. Iwasaki, M. Okada, K. Nakatani, and S. Sasayama
Mast Cells Cause Apoptosis of Cardiomyocytes and Proliferation of Other Intramyocardial Cells In Vitro
Circulation, September 28, 1999; 100(13): 1443 - 1449.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi
Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues
Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Takai, D. Jin, M. Sakaguchi, and M. Miyazaki
Chymase-Dependent Angiotensin II Formation in Human Vascular Tissue
Circulation, August 10, 1999; 100(6): 654 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. P. Rossi, A. Sacchetto, M. Cesari, and A. C Pessina
Interactions between endothelin-1 and the renin-angiotensin-aldosterone system
Cardiovasc Res, August 1, 1999; 43(2): 300 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. Inui, M. Yoshizumi, N. Okishima, H. Houchi, K. Tsuchiya, H. Kido, and T. Tamaki
Mechanism of endothelin-1-(1---31)-induced calcium signaling in human coronary artery smooth muscle cells
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1067 - E1072.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Yamaoka, K.-i. Masuda, H. Ogawa, K.-i. Takagi, N. Umemoto, and S. Yasuoka
Cloning and Characterization of the cDNA for Human Airway Trypsin-like Protease
J. Biol. Chem., May 8, 1998; 273(19): 11895 - 11901.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Tchougounova, E. Forsberg, G. Angelborg, L. Kjellen, and G. Pejler
Altered Processing of Fibronectin in Mice Lacking Heparin. A ROLE FOR HEPARIN-DEPENDENT MAST CELL CHYMASE IN FIBRONECTIN DEGRADATION
J. Biol. Chem., February 2, 2001; 276(6): 3772 - 3777.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.